Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma ; day:15 ; month:11 ; year:2024 ; pages:1-3
Bone marrow transplantation ; (15.11.2024), 1-3
- Creator
-
Richardson, Tim
Tharmaseelan, Hishan
Frenzel, Lukas
Gödel, Philipp
Fürstenau, Moritz
Nieper, Pascal
Braun, Till
Schütte, Daniel
Hallek, Michael
Scheid, Christof
Holtick, Udo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-024-02472-3
- URN
-
urn:nbn:de:101:1-2502040844055.872491128445
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Richardson, Tim
- Tharmaseelan, Hishan
- Frenzel, Lukas
- Gödel, Philipp
- Fürstenau, Moritz
- Nieper, Pascal
- Braun, Till
- Schütte, Daniel
- Hallek, Michael
- Scheid, Christof
- Holtick, Udo
- SpringerLink (Online service)
Other Objects (12)
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation
NFATc3 in der akuten GvHD
Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Established and Emerging Treatments of Skin GvHD
Rolle verschiedener T-Zell-Transkriptionsfaktoren in der akuten GvHD und GvL
Risikofaktoren für die akute GvHD nach allogener Stammzelltransplantation
Dendritisches Polyglycerolsulfat als neues Therapeutikum der akuten GvHD
Photopheresebehandlung bei chronischer Graft-versus-Host-Erkrankung (GvHD): retrospektive Analyse eines standardisierten klinischen Evaluationsschemas mit Fokus auf die kutane GvHD
Clinical and diagnostic pathology of graft versus host disease (GvHD)
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation
NFATc3 in der akuten GvHD
Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Established and Emerging Treatments of Skin GvHD
Rolle verschiedener T-Zell-Transkriptionsfaktoren in der akuten GvHD und GvL
Risikofaktoren für die akute GvHD nach allogener Stammzelltransplantation
Dendritisches Polyglycerolsulfat als neues Therapeutikum der akuten GvHD
Photopheresebehandlung bei chronischer Graft-versus-Host-Erkrankung (GvHD): retrospektive Analyse eines standardisierten klinischen Evaluationsschemas mit Fokus auf die kutane GvHD
Clinical and diagnostic pathology of graft versus host disease (GvHD)
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation
NFATc3 in der akuten GvHD
Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Established and Emerging Treatments of Skin GvHD
Rolle verschiedener T-Zell-Transkriptionsfaktoren in der akuten GvHD und GvL
Risikofaktoren für die akute GvHD nach allogener Stammzelltransplantation
Dendritisches Polyglycerolsulfat als neues Therapeutikum der akuten GvHD
Photopheresebehandlung bei chronischer Graft-versus-Host-Erkrankung (GvHD): retrospektive Analyse eines standardisierten klinischen Evaluationsschemas mit Fokus auf die kutane GvHD